Management of Euglycemic Diabetic Ketoacidosis

Initial Assessment and Stabilization

The American Diabetes Association recommends performing careful clinical and laboratory assessment to guide individualized treatment for euDKA, as presentations can range from mild hyperglycemia and acidosis to severe dehydration 1
Management goals for euDKA include restoration of circulatory volume, tissue perfusion, resolution of ketoacidosis, and correction of electrolyte imbalances 1
The underlying cause of euDKA, such as pancreatitis, should be treated concurrently with DKA management 1

Aggressive fluid management using isotonic saline (0.9% NaCl) at a rate of 15-20 mL/kg/hour is recommended for euDKA patients 2
Fluid replacement should continue to restore circulatory volume and improve tissue perfusion 1

Continuous intravenous insulin is the standard of care for critically ill or mentally obtunded euDKA patients 1
Blood glucose should be monitored every 2-4 hours and insulin adjusted accordingly 1

Serum electrolytes, particularly potassium, sodium, and phosphate, should be checked and replaced as needed in euDKA patients 2
Acid-base status should be monitored by checking venous pH and anion gap every 2-4 hours 3
Bicarbonate administration is generally not recommended for DKA patients, as it has been shown to make no difference in resolution of acidosis or time to discharge 1

Treatment success for euDKA is indicated by resolution of acidosis (pH >7.3), serum bicarbonate ≥18 mEq/L, anion gap ≤12 mEq/L, and improvement in clinical symptoms 3
Direct measurement of β-hydroxybutyrate in blood is the preferred method for monitoring DKA resolution 3

When transitioning to subcutaneous insulin, basal insulin should be administered 2-4 hours before stopping the intravenous insulin to prevent recurrence of ketoacidosis 1
Administration of a low dose of basal insulin analog in addition to intravenous insulin infusion may prevent rebound hyperglycemia without increased risk of hypoglycemia 1

Inadequate fluid resuscitation can worsen both DKA and pancreatitis 2
Premature discontinuation of insulin therapy before complete resolution of ketosis can lead to recurrence of DKA 3
Failure to monitor and replace electrolytes can lead to complications 2
Inadequate carbohydrate administration alongside insulin in euDKA can perpetuate ketosis 2